Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Should You Exit This Insurance Aggregator - SLQT

Feb 08, 2022 | Team Kalkine
Should You Exit This Insurance Aggregator - SLQT

SelectQuote, Inc.

SelectQuote, Inc. (NYSE: SLQT) is a Direct-to-Consumer (DTC) distribution platform that allows customers to purchase health, life, auto, and home insurance plans online. The company earns money by selling insurance products on behalf of its insurance carrier partners in exchange for a commission. It operates in SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home segments.

Why Should Investors Exit?

  • Topline and bottom line Stress: Due to a series of unforeseen issues in its core Senior segment during the current Medicare Advantage season, the company reported a decrease in total revenues to USD 194.98 million in Q2FY22 (ended December 31, 2021) from USD 357.57 million in Q2FY21. The company reported an increase in net losses to USD 137.01 million in Q2FY22 vs. a net profit of USD 89.86 million in Q2FY21. The company's net margin also fell to 24.0% in Q2FY22 vs. 41.5% in Q1FY22.
  • Leveraged Balance Sheet: With a Debt/Equity ratio of 1.44x as of December 31, 2021, compared to the industry norm of 0.25x, the company is exposed to a higher balance sheet risk than its peers. Furthermore, its long-term debt-to-total-capital ratio was 58.4%, compared to the industry median of 5.3% for the same period. These leveraged financials placed the corporation on the verge of enormous swings in response to even minor changes in interest rates.
  • High Cash Conversion Days: The company has a long Cash Conversion Cycle (Days) in comparison to the industry, which means it takes more days to convert its inventory to cash. Its Cash Cycle was 117.5 days in Q2FY22, compared to an industry median of 98.6 days.

Stock Recommendation:

SLQT's stock price has remained volatile, declining 73.19% in the past twelve months. The stock is currently trading below 50 and 200 DMA levels, indicating a bearish trend. Considering the fall in topline, bottom line stress, high cash conversion days, leveraged balance sheet risks, and other technical indicators, we recommend a "Sell" rating on the stock at the closing price of USD 6.53 as of February 07, 2022.

Three-Year Technical Price Chart (as of February 07, 2022). Analysis by Kalkine Group

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.


Disclaimer-

Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.

Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.